Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT05179057 · TERMINATED

Trial details

NCT number: NCT05179057
Sponsor: AlloVir
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Adenovirus Infection

Start date: 2022-04-26
Primary completion: 2024-01-31
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.